SCHEMBL31727729

SCHEMBL31727729

[2H]C([2H])([2H])Oc1nc(Cl)c2ncnc(N)c2c1OC(C)c1ncn(C(F)F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727961 0.87 — —
SCHEMBL31727795 0.82 — —
SCHEMBL31728933 0.78 PIK3CD (0.31) —
SCHEMBL31728370 0.77 SRC (0.30) —
SCHEMBL31727804 0.74 SRC (0.37) —
SCHEMBL31728513 0.71 — —
SCHEMBL31727755 0.70 SRC (0.34) —
SCHEMBL31728243 0.70 MET (0.34) —
SCHEMBL31728015 0.69 LRRK2 (0.31) —
SCHEMBL31728587 0.69 SRC (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback